Comparison of efficacy and safety of ombitasvir/paritaprevir/ ritonavir and dasabuvir ± ribavirin between Asian and western HCV GT1b-infected patients

Authors :: Roger Trinh
W.-L. Chuang
Lai Wei
Yan Luo
N. Mobashery
J. Enejosa
M.-L. Yu
Nancy S. Shulman
Linda M Fredrick
A. Campbell
Jeong Heo
S.W. Paik
Source :: Journal of Hepatology. 66:S531-S532
Publication Year :: 2017
Publisher :: Elsevier BV, 2017.

Subjects :: chemistry.chemical_compound
Dasabuvir
Hepatology
chemistry
business.industry
Ribavirin
Ombitasvir/paritaprevir/ritonavir
Medicine
business
Virology

Full Text Access

Tools